This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Analysis of effectiveness
The clinical study was analysed on the basis of treatment completers only. The primary health outcomes estimated in the analysis were the initial resection methods used for benign polyps, and several clinical outcomes. The clinical outcomes included complete endoscopic success (no polyp recurrence detectable at follow-up), the number of patients continuing endoscopic treatment, the number of patients whose endoscopic treatment failed, recurrence-free follow-up time, and complications. In terms of the comparability of the study groups, the authors showed that the polyps in the non-specialist group were larger than those in the specialist group. However, there were no statistically significant differences in the other polyp characteristics.
Effectiveness results
In terms of the initial resection methods used for benign polyps, the specialists attempted endoscopic resection more often (80 of the 86 cases) than non-specialists (15 out of 20), (p=0.03). Similarly, specialists used saline-assisted polypectomy techniques more often (38 of the 80 cases) than non-specialists (2 out of 15), (p=0.02).
Complete endoscopic success was achieved in 61 patients in the specialist group and in 6 patients in the non-specialist group, (p=0.01).
Six patients continued endoscopic treatment in the specialist group versus one in the non-specialist group.
The number of patients whose endoscopic treatment failed was 5 in each group.
In the overall group of patients, the median recurrence-free follow-up time was 11.7 months (range: 2.1 -64.2).
Complications occurred after three polypectomies in the specialist group and in one patient in the non-specialist group.
Clinical conclusions
The analysis of effectiveness showed that large sessile polyps could be removed endoscopically, but that the clinical outcomes improved when specialists rather than non-specialists treated the patients.
Measure of benefits used in the economic analysis
The health outcomes were left disaggregated and no summary benefit measure was used in the analysis. A costconsequences analysis was therefore conducted.
Direct costs
Discounting was not performed. It was unclear whether it was relevant, as the length of follow-up was not reported. The unit costs and the quantities of resources were reported separately. The health services included in the analysis were polypectomy, surgery for benign polyps (including operation and inpatient stay), and colonoscopy. The cost/resource boundary adopted in the study was that of the hospital. The quantities of resources were estimated from a sub-sample of patients included in the effectiveness analysis during 1995 to 2000. The cost data were obtained from the study hospital. No price year was reported.
